Mimedx (MDXG) Change in Receivables (2011 - 2026)

Mimedx (MDXG) has 15 years of Change in Receivables data on file, last reported at -$28.2 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Receivables fell 491.63% year-over-year to -$28.2 million; the trailing twelve-month figure through Mar 2026 stood at -$9.0 million (down 240.66% YoY), and the FY2025 full-year result was $26.4 million, up 934.25% from the prior year.
• Change in Receivables fell to -$28.2 million in Q1 2026, from $887000.0 in the prior quarter.
• In the past five years, Change in Receivables ranged from a high of $11.0 million in Q3 2025 to a low of -$28.2 million in Q1 2026.
• A 5-year average of $1.1 million and a median of $2.4 million in 2022 frame the typical range for Change in Receivables.
• Across the five-year window, Change in Receivables plunged 89200.0% in 2022 and jumped 1055.72% in 2025, its largest moves.
• Tracing MDXG's Change in Receivables over 5 years: stood at $2.6 million in 2022, then jumped by 111.13% to $5.6 million in 2023, then plunged by 59.61% to $2.3 million in 2024, then slumped by 60.63% to $887000.0 in 2025, then plunged by 3280.27% to -$28.2 million in 2026.
• Business Quant data shows MDXG's Change in Receivables at -$28.2 million in Q1 2026, $887000.0 in Q4 2025, and $11.0 million in Q3 2025.